Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hypoglycemic Agents" (37 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Hypoglycemia
Interventions: Drug: Exenatide;   Drug: Placebo
2 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
3 Recruiting Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
Condition: Type 2 Diabetes
Interventions: Other: 1: incretin-based therapy;   Other: 2: other antidiabetic
4 Recruiting Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
5 Recruiting Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Conditions: Prediabetes;   Obesity
Interventions: Drug: Exenatide;   Drug: Saxagliptin;   Drug: Exenatide ER;   Other: Placebo
6 Recruiting Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Ethanol;   Drug: Glucagon
7 Not yet recruiting The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
Condition: Hyperglycemia
Intervention: Drug: anti-diabetic drug
8 Recruiting Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
Conditions: Breast Cancer;   Bladder Cancer
Intervention:
9 Not yet recruiting Effect of Anti-diabetic Drugs on Glycemic Variability
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Dapagliflozin;   Drug: Gliclazide MR
10 Recruiting Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations
Condition: Diabetes Mellitus
Interventions: Other: Experimental Group instructions for glucose management via App;   Other: Placebo Comparator general instructions
11 Recruiting Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications
Condition: Acute Kidney Injury
Intervention:
12 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Placebo;   Drug: Exenatide
13 Recruiting Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea
Condition: Type 2 Diabetes
Intervention: Other: Observational
14 Recruiting Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine (U300);   Drug: Insulin glargine;   Drug: Non-insulin antihyperglycemic drugs
15 Recruiting Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine U100 (HOE901);   Drug: Metformin
16 Recruiting A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: Insulin degludec/insulin aspart;   Drug: Insulin glargine;   Drug: Insulin aspart
17 Recruiting A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: Insulin degludec/liraglutide;   Drug: Insulin degludec
18 Not yet recruiting Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
Conditions: Diabetes Mellitus;   Hypoglycemic Episodes
Interventions: Drug: Metformin;   Drug: Dapagliflozin;   Drug: Metformin up-titration
19 Recruiting A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Conditions: Type 1 Diabetes;   Severe Hypoglycemic Unawareness
Intervention: Biological: Islet Cell Transplant
20 Recruiting The Practical Evidence of Antidiabetic Combination Therapy in Korea
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: alogliptin;   Drug: Pioglitazone;   Drug: alogliptin + pioglitazone

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.